Global Pulmonary Function Testing Market, By Type (Portable PFT Systems, Complete PFT Systems), Test (Spirometry, Peak flow meter, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), Component (Software, Hardware, Service), Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), End-User (Hospitals, Clinical Laboratories, Diagnostics Laboratories, Homecare Settings),Distribution Channel ( Brick and Mortar, E-commerce) – Industry Trends and Forecast to 2031.
Pulmonary Function Testing Market Analysis and Size
The pulmonary function testing market utilizes advanced technologies such as spirometry, plethysmography, and gas diffusion tests to assess lung function. Additionally, innovations such as portable spirometers and computerized systems enhance accuracy, efficiency, and accessibility in diagnosing respiratory conditions such as asthma, COPD, and interstitial lung diseases.
Data Bridge Market Research analyses that the global pulmonary function testing market, which was USD 575.50 million in 2023, is expected to reach USD 937.52 million by 2031, and is expected to undergo a CAGR of 6.29% during the forecast period of 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pulmonary Function Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Portable PFT Systems, Complete PFT Systems), Test (Spirometry, Peak flow meter, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing), Component (Software, Hardware, Service), Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease), End-User (Hospitals, Clinical Laboratories, Diagnostics Laboratories, Homecare Settings),Distribution Channel ( Brick and Mortar, E-commerce)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
BD (U.S.), SCHILLER (Switzerland), COSMED srl (Italy), NSPIRE Healthcare (U.S.), MGC DIAGNOSTICS CORPORATION (U.S.), ndd Medical Technologies (Switzerland), Morgan Scientific, Inc. (U.S.), Ganshorn Medizin Electronic GmbH (Germany), Minato Holdings Inc. (Japan), CHEST M.I., Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), medical equipment europe GmbH (Netherlands), Omron Healthcare, Inc. (Japan), Medtronic (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Pulmonary function testing assesses lung capacity and function, crucial for diagnosing respiratory conditions. Common tests include spirometry, measuring the amount and speed of inhaled/exhaled air, and lung volume tests, evaluating lung capacity. These assessments aid in diagnosing conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.
Global Pulmonary Function Testing Market Dynamics
Drivers
- Growing Awareness and Screening Programs Towards Lung Function
Growing awareness of lung health and active engagement in respiratory screening initiatives propel the pulmonary function testing market's growth. With a focus on preventive healthcare, there is an escalating demand for precise lung function assessments, driving the market forward as individuals prioritize proactive measures for respiratory well-being.
- Increasing Respiratory Disorders leads to Early Detection
The surge in respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis fuels the demand for pulmonary function testing. These tests play a crucial role in enabling early detection and efficient management of respiratory conditions, thereby improving patient outcomes and quality of life through timely intervention and treatment.
Opportunities
- Telemedicine and Remote Monitoring Improving Accessibility
The integration of pulmonary function testing devices into telemedicine and remote monitoring solutions presents an opportunity to extend respiratory diagnostics to underserved areas. Through leveraging virtual healthcare platforms, patients can access accurate lung function assessments remotely, improving accessibility and facilitating early detection and management of respiratory conditions in regions with limited healthcare resources.
- Expansion of Healthcare Facilities in Rural and Semi-Urban Regions
The expansion of healthcare facilities, notably in rural and semi-urban regions, creates avenues for the deployment of pulmonary function testing equipment. This trend facilitates enhanced accessibility to respiratory diagnostics, ensuring timely detection and management of pulmonary disorders. The increased availability of such facilities drives the utilization of pulmonary function testing devices, fostering market growth in these areas.
Restraints/Challenges
- Risk of Infection Transmission During Test
The risk of infection transmission during pulmonary function testing poses a significant challenge for the market, particularly in settings lacking proper infection control measures. Concerns about potential transmission of infectious diseases can deter patients from undergoing testing and lead to increased healthcare-associated infections, impacting market demand and trust.
- High Cost of Equipment Impact Smaller Healthcare Facilities
The high cost of pulmonary function testing equipment hampers market growth by restricting access for smaller healthcare facilities and hindering penetration in certain regions. This limitation prevents widespread adoption of pulmonary function testing services, thereby impeding the market's expansion and potential to address respiratory health needs effectively.
This global pulmonary function testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pulmonary function testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In April 2021, VYAIRE launched ARTIQ PFT, an automated tool for interpreting pulmonary function tests using artificial intelligence, benefiting pulmonologists with standardized diagnostic interpretation. This innovation could drive increased demand from hospitals and diagnostic laboratories, thus fostering growth in the pulmonary function testing market
- In September 2020, Biodex Medical Systems Inc. was acquired by Mirion Technologies, merging portfolios to extend Mirion's presence in the medical field, enhancing offerings in the pulmonary function testing market, and potentially increasing accessibility to advanced diagnostic tools for healthcare facilities worldwide
- In January 2020, VYAIRE entered a distribution agreement with Spirosure Inc. for the Fenom Pro Asthma monitor, expanding the reach of FeNO measurement technology in top respiratory labs across the U.S. and Europe. This partnership is poised to boost the pulmonary function testing market by enhancing diagnostic capabilities for asthma management
Global Pulmonary Function Testing Market Scope
The global pulmonary function testing market is segmented on the basis of type, test, component, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Portable PFT Systems
- Complete PFT Systems
Test
- Spirometry
- Peak flow meter
- Lung Volume
- Gas Exchange Testing
- Maximal Voluntary Ventilation
- Oxygen Titration Test
- High Altitude Simulation Testing
Component
- Software
- Hardware
- Service
Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Chronic Shortness of Breath
- Restrictive Lung Disease
End-User
- Hospitals
- Clinical Laboratories
- Diagnostics Laboratories
- Homecare Settings
Distribution Channel
- Brick and Mortar
- E-commerce
Global Pulmonary Function Testing Market Regional Analysis/Insights
The global pulmonary function testing market is analysed and market size insights and trends are provided by country, type, test, component, application, end-user, and distribution channel as referenced above.
The countries covered in the global pulmonary function testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the pulmonary function testing market, propelled by advanced diagnostics, robust healthcare infrastructure, and a rising incidence of respiratory illnesses. The region's focus on technological advancements and the prevalence of pulmonary disorders contribute to its dominance in this critical healthcare segment.
Asia-Pacific is expected to experience the most rapid growth in the pulmonary function testing market from 2024 to 2031. This surge is attributed to rising demand for such devices in private hospitals and clinics across the region, reflecting increased emphasis on respiratory health management.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global pulmonary function testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global pulmonary function testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global pulmonary function testing market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Pulmonary Function Testing Market Share Analysis
The global pulmonary function testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pulmonary function testing market.
Some of the major players operating in the global pulmonary function testing market are:
- BD (U.S.)
- SCHILLER (Switzerland)
- COSMED srl (Italy)
- NSPIRE Healthcare (U.S.)
- MGC DIAGNOSTICS CORPORATION (U.S.)
- ndd Medical Technologies (Switzerland)
- Morgan Scientific, Inc. (U.S.)
- Ganshorn Medizin Electronic GmbH (Germany)
- Minato Holdings Inc. (Japan)
- CHEST M.I., Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- medical equipment europe GmbH (Netherlands)
- Omron Healthcare, Inc. (Japan)
- Medtronic (U.S.)
SKU-